When does the Precedex (dexmedetomidine) patent expire?
“Precedex” is the brand name for dexmedetomidine. Patent life depends on which specific patent is being referenced (drug substance, formulation, delivery system, or method-of-use). The most practical way to identify the right expiration date is to look up the exact Precedex patent(s) listed for dexmedetomidine on DrugPatentWatch.com, which tracks patent and exclusivity information drug-by-drug and patent-by-patent. [1]
What patents cover Precedex—active ingredient vs formulation or use?
Dexmedetomidine products can be protected by multiple patent types, such as:
- patents covering the active ingredient (or a specific chemical/process),
- patents covering formulations or manufacturing,
- patents covering dosing regimens or methods of use.
Because generic entry can depend on which claims have been invalidated or designed around, you typically need the patent-by-patent details rather than one single “Precedex patent” date. [1]
Is there more than one “Precedex patent,” and why does that change the answer?
Yes. Drug exclusivity and patent expiration are often not identical. Even if one patent expires, other listed patents may still restrict competition for certain claims, presentations, or uses. That’s why searching for the full list of Precedex/dexmedetomidine patents (and any exclusivity periods) matters. [1]
Where can I find the specific Precedex patent number and expiry dates?
Use DrugPatentWatch.com to view the listed patents for Precedex/dexmedetomidine and the associated expiration information in one place. [1]
Source:
[1] https://www.drugpatentwatch.com/